Neuronetics (STIM) Gross Profit Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 12.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.33% |
| Dec 31, 2025 | 16.27% |
| Sep 30, 2025 | 9.79% |
| Jun 30, 2025 | 13.05% |
| Mar 31, 2025 | 13.74% |
| Dec 31, 2024 | 9.05% |
| Sep 30, 2024 | 9.53% |
| Jun 30, 2024 | 2.07% |
| Mar 31, 2024 | 9.14% |
| Dec 31, 2023 | 10.10% |
| Sep 30, 2023 | 6.31% |
| Jun 30, 2023 | 19.86% |
| Mar 31, 2023 | 9.56% |
| Dec 31, 2022 | 1.67% |
| Sep 30, 2022 | 3.07% |
| Jun 30, 2022 | -0.30% |
| Mar 31, 2022 | 2.54% |
| Dec 31, 2021 | -1.25% |
| Sep 30, 2021 | -0.15% |
| Jun 30, 2021 | 4.60% |
| Mar 31, 2021 | 9.37% |
| Dec 31, 2020 | 8.89% |
| Sep 30, 2020 | 7.62% |
| Jun 30, 2020 | -1.69% |
| Mar 31, 2020 | 13.11% |